Learn more about whether Recursion Pharmaceuticals, Inc. or Viridian Therapeutics, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Achieved $30 million milestone from Roche and Genentech for delivering a whole-genome map of microglial immune cells—the second neuro map designed to accelerate treatments for a wide range of ...

Recursion announced Najat Khan, PhD, currently chief R&D and commercial officer and a board member, will succeed co-founder and CEO Chris Gibson, PhD as CEO and president. Khan will also continue in ...

SALT LAKE CITY (AP) — SALT LAKE CITY (AP) — Recursion Pharmaceuticals Inc. (RXRX) on Wednesday reported a loss of $162.3 million in its third quarter. The Salt Lake City-based company said it had a ...

Salt Lake City, Utah, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, today announced that its Board ...

Batman and Robin #27 hits stores this Wednesday! A mysterious new villain targets Gotham's rogues gallery. Who's hunting the ...

No matter how much more famous The Dark Knight might be, some of Image's Rogues Gallery could take down DC Comics' Bat.

For consumers, however, the incentives look weaker. Credit cards offer rich rewards programs, while deposits and money-market funds pay interest. By contrast, the GENIUS Act explicitly prohibits ...

Merlin Egalite, co-founder of Morpho Labs, addressed the issue of temporary liquidity shortages in certain Morpho vaults on ...

Learn how Claude's ability to monitor its internal states could transform AI safety and provide insights into human brain ...

When I introduced Steven Pinker, it felt like our worldviews couldn't have been more different. Here's why that dissonance was exactly the point.

Stream's collapse shows operational risk extends beyond smart contracts to fund managers and custody, an expert told Decrypt.